Groww shares hit 20% upper circuit, extend post-listing gains to 59% in 4 sessions; m-cap reaches Rs 1.1 lakh crore
Groww shares have gained 54 percent since listing on November 12.
Reduce Alkem Labs; target of Rs 5850: Choice Institutional Equities
Choice Institutional Equities recommended reduce rating on Alkem Labs with a target price of Rs 5850 in its research report dated November 17, 2025.
Buy Man Industries; target of Rs 600: Choice Institutional Equities
Choice Institutional Equities is bullish on Man Industries has recommended buy rating on the stock with a target price of Rs 600 in its research report dated November 17, 2025.
Buy Tilaknagar Inds; target of Rs 650: Choice Institutional Equities
Choice Institutional Equities is bullish on Tilaknagar Inds has recommended buy rating on the stock with a target price of Rs 650 in its research report dated November 17, 2025.
Buy Yatharth Hospitals; target of Rs 1050: Choice Institutional Equities
Choice Institutional Equities is bullish on Yatharth Hospitals has recommended buy rating on the stock with a target price of Rs 1050 in its research report dated November 17, 2025.
Buy Rainbow Childrens Medicare; target of Rs 1685: Choice Institutional Equities
Choice Institutional Equities is bullish on Rainbow Childrens Medicare has recommended buy rating on the stock with a target price of Rs 1685 in its research report dated November 17, 2025.
Buy Fortis Healthcare; target of Rs 1150: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 1150 in its research report dated November 12, 2025.
Buy Hindustan Aeronautics; target of Rs 5507: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Hindustan Aeronautics has recommended buy rating on the stock with a target price of Rs 5507 in its research report dated November 12, 2025.
Buy Cera Sanitaryware; target of Rs 7178: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Cera Sanitaryware has recommended buy rating on the stock with a target price of Rs 7178 in its research report dated November 13, 2025.
Buy Ipca Laboratories; target of Rs 1600: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1600 in its research report dated November 17, 2025.
Buy Apeejay Surrendra Park Hotels; target of Rs 235: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Apeejay Surrendra Park Hotels has recommended buy rating on the stock with a target price of Rs 235 in its research report dated November 17, 2025.
SpiceJet shares rise 5% as airline expects operational fleet to double by 2025-end
SpiceJet share price: The airline said that higher capacity and better aircraft utilisation are expected to materially improve CASK and lift overall profitability.
Q2 results impact: Marico shares jump 3% as analysts see EBITDA growth in H2; should you buy, sell or hold?
Marico share price: JM Financial kept a ‘Buy’ call on the stock, and raised its target price to Rs 850 per share from Rs 825 per share.
RateGain – Should the outsized acquisition be the key draw for investors?
The rally in the stock in the past four months captures much of the optimism about the large inorganic move
LG Electronics India Q2: One-off demand disruption not to affect the core thesis
Strong industry tailwinds, leadership position, and export potential to support growth
Marico Q2 FY26: Strong top-line growth; margin pressure to ease
The company has a diversified growth agenda and its execution capabilities are strong
Tata Motors PV shares crash 6% today after weak Q2, JLR guidance cut; analysts flag margin, output pressures
Tata Motors share price crashed as much as 6% today as analysts weighed the depth of JLR’s disruption, the scale of the EBITDA loss, and a divided stance on the near-term recovery path.
Nifty Headed For All-Time Highs After Friday’s Late Recovery?| Opening Bell Live
The Nifty 50 and Bank Nifty ended the week (Nov 14) on a strong note, closing above the previous week’s highs with supportive technical and momentum signals. For the Nifty 50, sustaining above Friday’s peak near 26,000 could open the door to 26,100 and then 26,300, while key support lies at 25,800–25,700. Bank Nifty, meanwhile, must clear 58,600 for an upside toward 59,000 and fresh record territory, with 58,100–58,000 acting as immediate support. With earnings season behind us and Bihar polls out of the way, markets will track developments on the India–US trade deal. Stocks in focus today include Tata Motors (PV) post the JLR guidance cut, Max Healthcare, and IRB Infra. Catch Nandita Khemka in conversation with Rajesh Palviya of Axis Securities and market veteran Ajay Bagga for the full market setup.
After a spectacular rerating, what next for Fortis Healthcare?
The company aims to improve profit margins to 25 percent from 20.5 percent in FY25
IRB Infrastructure share price rises 5% after arm bags project of Rs 9,270 crore
IRB Infrastructure Share Price | The company's arm IRB Infrastructure Trust bagged a project worth Rs 9,270 crore.
Alembic Pharma shares gain 2% on USFDA nod for Diltiazem Hydrochloride tablets
Alembic Pharmaceuticals Share Price | The tablets are indicated for the management of chronic stable angina and angina due to coronary artery spasm.
First Tick: Top global cues to watch in today’s trade
Wall Street ended mixed on Friday as investors awaited Nvidia’s results next week and fretted that the Federal Reserve may delay a December rate cut.
Closing Bell: Market rises on 6th day; Nifty above 26,000, Sensex jumps 388 pts
Bajaj Auto, Tata Consumer, Eicher Motors, Max Healthcare, Maruti Suzuki were among major gainers on the Nifty, while losers were TMPV, Adani Enterprises, Jio Financial, Interglobe Aviation, UltraTech Cement. All the other sectoral indices ended in the green with auto, bank, realty, capital goods, consumer durables, PSU Bank up 0.5-1%. BSE Midcap and smallcap indices rose 0.6% each.
Asian stocks have cautious start, bitcoin in focus
Japan edged lower along with Australia, while South Korean equities rose. The yen held steady after Japan’s economy contracted for the first time in six quarters.
